1192 Participants Needed

Supplemental Oxygen for Airway Management

(OPTIMISE-2 Trial)

Recruiting at 6 trial locations
AF
TR
Overseen ByThomas Riva, MD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests the optimal oxygen flow rate for young patients undergoing tracheal intubation, a procedure to assist breathing. Researchers aim to determine if a significant difference exists between low-flow and high-flow oxygen during this procedure. The trial compares two groups: one using low-flow nasal supplemental oxygen and the other using high-flow nasal supplemental oxygen. It seeks newborns and infants up to 52 weeks old who require intubation for planned or semi-urgent surgeries. As an unphased trial, this study provides a unique opportunity for patients to contribute to important research that could enhance future medical procedures.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this method is safe for airway management?

Research has shown that both low-flow and high-flow oxygen are generally safe during the insertion of a breathing tube. One study found that high-flow oxygen maintained better oxygen levels than low-flow oxygen in some situations. Despite this, low-flow oxygen remains widely used and is usually well-tolerated. Another study found that low-flow oxygen sometimes resulted in lower oxygen levels after tube insertion, but serious side effects were rare.

Overall, medical settings safely use both methods. While low-flow oxygen might not boost oxygen levels as effectively as high-flow oxygen, it remains a safe choice for many patients.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores different approaches to delivering supplemental oxygen during tracheal intubation, which is crucial for maintaining patient safety. The intervention group uses a low-flow nasal supplemental oxygen method, providing 0.2 L/kg/min FiO2 1.0, which could offer a gentler alternative to high-flow systems. On the other hand, the control group uses high-flow nasal supplemental oxygen at 2 L/kg/min FiO2 1.0, a more common practice. This trial aims to assess whether the low-flow method is as effective as the high-flow approach, potentially leading to more tailored oxygen delivery strategies during airway management.

What evidence suggests that this trial's treatments could be effective for airway management?

Research has shown that high-flow nasal oxygen (HFNO) helps maintain better oxygen levels during tracheal intubation. In this trial, participants in the control group will receive high-flow nasal supplemental oxygen. Studies have linked this to higher minimum oxygen levels, indicating generally better oxygen levels for patients. Conversely, participants in the intervention group will receive low-flow nasal supplemental oxygen, which has been associated with lower oxygen levels in some cases. For example, one study found that after intubation, only 12.9% of patients using high-flow oxygen experienced low oxygen levels, compared to 57.1% of those using low-flow oxygen. This evidence suggests that high-flow oxygen may be more effective at maintaining stable oxygen levels during intubation.678910

Who Is on the Research Team?

TR

Thomas Riva, MD

Principal Investigator

University of Bern

Are You a Good Fit for This Trial?

This trial is for neonates and infants up to 52 weeks postconceptual age who need oral or nasal tracheal intubation for various medical procedures. Legal guardians must consent. It's not suitable for those outside this age range or without guardian consent.

Inclusion Criteria

My child needs a breathing tube for a planned or urgent procedure.
My child is under 52 weeks old and I can provide consent for them.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Preparation and Induction

Eligible children are prepared for intubation according to local SOPs, including pre-oxygenation and administration of anesthesia and neuromuscular blocking agents.

1 day
1 visit (in-person)

Intubation Procedure

Tracheal intubation is performed with randomized low-flow or high-flow supplemental oxygen using the C-MAC video laryngoscope.

15 minutes
1 visit (in-person)

Follow-up

Participants are monitored for respiratory complications and other outcomes within the first 24 hours post-intubation.

24 hours

What Are the Treatments Tested in This Trial?

Interventions

  • High-flow nasal supplemental oxygen
  • Laryngoscopy
  • Low-flow nasal supplemental oxygen
  • Tracheal Intubation
Trial Overview The study compares high-flow versus low-flow supplemental oxygen during tracheal intubation using a C-MAC video laryngoscope in young patients. The goal is to find the best oxygen flow rate needed during this procedure.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Group II: Control groupActive Control1 Intervention

Laryngoscopy is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:

🇪🇺
Approved in European Union as Laryngoscopy for:
🇺🇸
Approved in United States as Laryngoscopy for:
🇨🇦
Approved in Canada as Laryngoscopy for:
🇯🇵
Approved in Japan as Laryngoscopy for:
🇨🇳
Approved in China as Laryngoscopy for:
🇨🇭
Approved in Switzerland as Laryngoscopy for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Thomas Riva

Lead Sponsor

Trials
4
Recruited
109,000+

Insel Gruppe AG, University Hospital Bern

Lead Sponsor

Trials
831
Recruited
2,353,000+

Istituto Giannina Gaslini

Collaborator

Trials
47
Recruited
140,000+

Royal Perth Hospital

Collaborator

Trials
19
Recruited
11,000+

University Hospital, Geneva

Collaborator

Trials
522
Recruited
1,868,000+

Centre Hospitalier Universitaire Vaudois

Collaborator

Trials
269
Recruited
14,040,000+

Luzerner Kantonsspital

Collaborator

Trials
90
Recruited
326,000+

Charite University, Berlin, Germany

Collaborator

Trials
1,071
Recruited
3,739,000+

Gaslini Children's Hospital

Collaborator

Trials
7
Recruited
107,000+

The Hospital for Sick Children

Collaborator

Trials
724
Recruited
6,969,000+

Published Research Related to This Trial

In a study of 67 awake patients undergoing flexible bronchoscopy, it was found that routine oxygen supplementation is not necessary for the procedure, as only 50.7% of patients required it.
The baseline oxygen saturation level was a key predictor for the need for supplemental oxygen, with all patients needing it having a baseline saturation of 92% or lower, highlighting the importance of monitoring oxygen levels before the procedure.
Oxygen supplementation during awake fibreoptic bronchoscopy in a Nigerian tertiary hospital.Onakpoya, UU., Adewole, O., Ogunrombi, AB., et al.[2013]
Apnoeic oxygenation during tracheal intubation in children significantly increases the first-pass success rate without causing physiological instability, as shown in a systematic review of 15 studies involving 9802 children.
This technique also helps maintain higher oxygen saturation levels and reduces the incidence of hypoxaemia, indicating its effectiveness in improving safety during intubation procedures.
Apnoeic oxygenation during paediatric tracheal intubation: a systematic review and meta-analysis.Fuchs, A., Koepp, G., Huber, M., et al.[2023]
In a study involving 250 neonates and infants, video laryngoscopy was found to significantly improve the first-attempt tracheal intubation success rate (89.3%) compared to direct laryngoscopy (78.9%) when both techniques were used with supplemental oxygen.
The incidence of adverse events was similar between the two groups, indicating that video laryngoscopy is a safe alternative and should be considered the preferred method for intubating neonates and infants.
Direct versus video laryngoscopy with standard blades for neonatal and infant tracheal intubation with supplemental oxygen: a multicentre, non-inferiority, randomised controlled trial.Riva, T., Engelhardt, T., Basciani, R., et al.[2023]

Citations

Effectiveness of high-flow nasal cannula for tracheal ...We found that the use of HFNC during tracheal intubation was potentially associated with a higher lowest SpO 2 during the procedure in comparison to ...
Efficacy of high-flow nasal oxygenation compared with ...This randomised study shows that high-flow nasal oxygenation may be as effective as tracheal intubation in oxygenation during laryngeal microsurgery.
A propensity score-adjusted analysis of efficacy of high- ...Our findings suggest that HFNO was associated with improved lowest oxygen saturation and a lower rate of multiple attempts during ATI.
High-Flow Nasal Oxygen versus Mechanical Ventilation... ...Primary outcome was intraoperative respiratory support success rate, which was defined as peripheral oxygen saturation greater than 94% and transcutaneous ...
Nasal High-Flow Therapy during Neonatal Endotracheal ...We performed a randomized, controlled trial to compare nasal high-flow therapy with standard care (no nasal high-flow therapy or supplemental ...
Randomized controlled trial to assess the effectiveness of ...This randomized controlled trial evaluated whether apnoeic oxygenation using HFNC or LFNC with head elevation improves oxygenation and intubation outcomes
Evidence-based Emergency Tracheal IntubationHypotension occurs during 25–40% of emergency tracheal intubations and may be associated with an increased risk of cardiac arrest and death (2, ...
Study Details | NCT05967507 | Laryngoscopy for Neonatal ...This study aims to investigate the optimal oxygen flow rate needed during tracheal intubation with the C-MAC video laryngoscope (Karl Storz, Tuttlingen, ...
Effect of Noninvasive Respiratory Strategies on Intubation ...An initial strategy of CPAP significantly reduced the risk of tracheal intubation or mortality compared with conventional oxygen therapy.
143 A Randomized Control Trial to Assess Effectiveness ...Post intubation non-invasive oxygen saturation < 92% was seen in 4 [12.9%] in high flow, 16 [57.1%] in low flow and 7 [20%] in standard arm with a p-value of < ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security